DNA Hypomethylation of the MPO Gene in Peripheral Blood Leukocytes Is Associated with Cerebral Stroke in the Acute Phase
Autor: | Egor Churkin, Alexey Polonikov, Ekaterina Barysheva, M.S. Nazarenko, Vladimir P. Ivanov, Andrey E Belykh, Olga Bushueva, I.A. Koroleva, A.V. Markov |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
medicine.medical_specialty biology business.industry GCLM General Medicine Methylation Pathogenesis 03 medical and health sciences Cellular and Molecular Neuroscience 030104 developmental biology 0302 clinical medicine Endocrinology CpG site Internal medicine Myeloperoxidase DNA methylation medicine biology.protein Epigenetics business 030217 neurology & neurosurgery DNA hypomethylation |
Zdroj: | Journal of Molecular Neuroscience. 71:1914-1932 |
ISSN: | 1559-1166 0895-8696 |
DOI: | 10.1007/s12031-021-01840-8 |
Popis: | Dysregulation of the oxidant-antioxidant system contributes to the pathogenesis of cerebral stroke (CS). Epigenetic changes of redox homeostasis genes, such as glutamate-cysteine ligase (GCLM), glutathione-S-transferase-P1 (GSTP1), thioredoxin reductase 1 (TXNRD1), and myeloperoxidase (MPO), may be biomarkers of CS. In this study, we assessed the association of DNA methylation levels of these genes with CS and clinical features of CS. We quantitatively analyzed DNA methylation patterns in the promoter or regulatory regions of 4 genes (GCLM, GSTP1, TXNRD1, and MPO) in peripheral blood leukocytes of 59 patients with CS in the acute phase and in 83 relatively healthy individuals (controls) without cardiovascular and cerebrovascular diseases. We found that in both groups, the methylation level of CpG sites in genes TXNRD1 and GSTP1 was ≤ 5%. Lower methylation levels were registered at a CpG site (chr1:94,374,293, GRCh37 [hg19]) in GCLM in patients with ischemic stroke compared with the control group (9% [7%; 11.6%] (median and interquartile range) versus 14.7% [10.4%; 23%], respectively, p |
Databáze: | OpenAIRE |
Externí odkaz: |